{
    "title": "Medical Care Injury Compensation Reform Act of 1993",
    "content": "SYSTEMS\n\nSEC. 101. GRANTS TO STATES.\n\n    (a) In General.--The Secretary shall make grants to States for the \nimplementation and evaluation of alternative dispute resolution \nsystems.\n    (b) Eligibility.--A State is eligible to receive a grant under this \nsection if the State submits to the Secretary an application at such \ntime, in such form, and containing such information and assurances as \nthe Secretary may require, including--\n            (1) a description of the alternative dispute resolution \n        system that the State intends to implement with amounts \n        received under the grant;\n            (2) assurances that the State will comply with all data \n        gathering requirements promulgated by the Secretary under \n        section 102(a); and\n            (3) any information and assurances necessary to enable the \n        Secretary to determine whether the State's alternative dispute \n        resolution system meets the qualification standards for such \n        systems developed by the Secretary under section 102(a).\n    (c) Number of Grants.--\n            (1) In general.--Except as provided in paragraph (2), the \n        Secretary shall award not less than 10 grants each fiscal year \n        under this section.\n            (2) Exception.--Notwithstanding paragraph (1), the \n        Secretary may award less than 10 grants under this section in a \n        fiscal year if the Secretary determines that there are an \n        inadequate number of applications submitted that meet the \n        eligibility and approval requirements of this section in such \n        fiscal year.\n    (d) Designation of Model States.--\n            (1) In general.--The Secretary shall designate each State \n        receiving a grant under this section as a model alternative \n        dispute resolution State.\n            (2) Extension of period of grant.--Upon application to the \n        Secretary, a State designated under paragraph (1) shall be \n        eligible for a 2-year extension of the grant received under \n        this section.\n            (3) Dissemination of information to other states.--The \n        Secretary shall disseminate information on the alternative \n        dispute resolution systems implemented by the States designated \n        under paragraph (1) to other States, health care professionals, \n        health care providers, and other interested parties.\n\nSEC. 102. ADMINISTRATION.\n\n    (a) Standards and Regulations for Alternative Dispute Resolution \nGrant Program.--\n            (1) In general.--In consultation with the Director of the \n        Agency for Health Care Policy and Research, the Secretary shall \n        develop and promulgate standards and regulations necessary to \n        carry out the grant program established under section 101, \n        including--\n                    (A) qualification standards for alternative dispute \n                resolution systems that States must meet in order to \n                receive grants under such section; and\n                    (B) regulations establishing data gathering \n                requirements for States receiving grants under such \n                section.\n            (2) Criteria for programs.--In developing qualification \n        standards for alternative dispute resolution systems under \n        paragraph (1)(A), the Secretary shall take into account the \n        effectiveness of such systems in--\n                    (A) supporting access to health care;\n                    (B) encouraging improvements in the quality of \n                health care;\n                    (C) enhancing and not impairing the physician-\n                patient relationship;\n                    (D) encouraging innovation that leads to an \n                improved level of health care;\n                    (E) compensating for avoidable medical injury due \n                to provider fault and not compensating for injury which \n                is unavoidable by standard medical practice;\n                    (F) resolving claims promptly and in amounts \n                proportional to the injury;\n                    (G) providing predictable outcomes; and\n                    (H) operating efficiently in terms of financial \n                costs, professional energies, and governmental \n                processes.\n    (b) Technical Assistance.--The Secretary shall provide States with \ntechnical assistance to enable States to submit applications for grants \nunder section 101, including information on the establishment and \noperation of alternative dispute resolution systems.\n    (c) Evaluation of Alternative Dispute Resolution Systems.--Not \nlater than 4 years after awarding the first grant to a State under \nsection 101, the Secretary shall prepare and submit to Congress a \nreport describing and evaluating the alternative dispute resolution \nsystems implemented by States with funds provided under such grants, \nand shall include in the report--\n            (1) information on--\n                    (A) the effect of such systems on the cost of \n                health care within the State,\n                    (B) the impact of such systems on the access of \n                individuals to health care within the State, and\n                    (C) the effect of such systems on the quality of \n                health care provided within such State; and\n            (2) an analysis of the feasibility and desirability of \n        establishing a national alternative dispute resolution system.\n\n           TITLE II--UNIFORM STANDARDS FOR MALPRACTICE CLAIMS\n\nSEC. 201. APPLICABILITY.\n\n    Except as provided in section 209, this title shall apply to any \nhealth care liability action brought in a Federal or State court and to \nany medical malpractice claim or medical product liability claim \nsubject to an alternative dispute resolution system.\n\nSEC. 202. CALCULATION AND PAYMENT OF DAMAGES.\n\n    (a) Periodic Payments for Future Losses.--No person may be required \nto pay more than $100,000 in a single payment in damages (whether for \neconomic or noneconomic losses) for expenses to be incurred in the \nfuture, but shall be permitted to make such payments on a periodic \nbasis. The periods for such payments shall be determined by the court, \nbased upon projections of when such expenses are likely to be incurred.\n    (b) Limitation on Noneconomic Losses.--The total amount of damages \nthat may be awarded to an individual and the family members of such \nindividual for noneconomic losses resulting from an injury which is the \nsubject of an action or claim may not exceed $250,000, regardless of \nthe number of health care professionals, health care providers, and \nhealth care producers against whom the action or claim is brought or \nthe number of actions or claims brought with respect to the injury.\n    (c) Mandatory Offsets for Damages Paid by a Collateral Source.--\n            (1) In general.--The total amount of damages received by an \n        individual shall be reduced (in accordance with paragraph (2)) \n        by any other payment that has been or will be made to the \n        individual to compensate the individual for the injury that was \n        the subject of the action or claim.\n            (2) Amount of reduction.--The amount by which an award of \n        damages to an individual shall be reduced under paragraph (1) \n        shall be--\n                    (A) the total amount of any payments (other than \n                such award) that have been made or that will be made to \n                the individual to compensate the individual for the \n                injury that was the subject of the action or claim; \n                minus\n                    (B) the amount paid by the individual (or by the \n                spouse, parent, or legal guardian of the individual) to \n                secure the payments described in subparagraph (A).\n    (d) Attorney's Fees.--A claimant's attorney's fees may not exceed--\n            (1) 25 percent of the first $150,000 of any award or \n        settlement paid to the claimant; or\n            (2) 15 percent of any additional amounts paid to the \n        claimant.\n    (e) Limitation on Punitive Damages.--The total amount of punitive \ndamages that may be assessed with respect to an action or claim may not \nexceed twice the total amount of the damages awarded to compensate the \nclaimant for losses resulting from the injury which is the subject of \nthe claim or action, regardless of the number of health care \nprofessionals, health care providers, and health care producers against \nwhom the action or claim is brought or the number of actions or claims \nbrought with respect to the injury.\n\nSEC. 203. JOINT AND SEVERAL LIABILITY FOR NONECONOMIC LOSSES.\n\n    The liability of each defendant for noneconomic losses shall be \nseveral only and shall not be joint, and each defendant shall be liable \nonly for the amount of noneconomic losses allocated to the defendant in \ndirect proportion to the defendant's percentage of responsibility (as \ndetermined by the trier of fact).\n\nSEC. 204. UNIFORM STATUTE OF LIMITATIONS.\n\n    (a) In General.--No medical malpractice claim or medical product \nliability claim may be initiated after the expiration of the 2-year \nperiod that begins on the earlier of the date which the alleged injury \nthat is the subject of such action was discovered or the date on which \nsuch injury should reasonably have been discovered, but in no event \nafter the expiration of the 4-year period that begins on the date the \nalleged injury occurred.\n    (b) Exception for Minors.--In the case of an alleged injury \nsuffered by a minor who has not attained 6 years of age, no medical \nmalpractice liability claim or medical product liability claim may be \nbrought after the expiration of the 2-year period that begins on the \ndate the alleged injury that is the subject of the action should \nreasonably have been discovered, but in no event after the date on \nwhich the minor attains 10 years of age.\n\nSEC. 205. SPECIAL PROVISION FOR CERTAIN OBSTETRIC SERVICES.\n\n    (a) In General.--In the case of a medical malpractice claim or \nmedical product liability claim relating to services provided during \nlabor or the delivery of a baby, if the defendant health care \nprofessional did not previously treat the plaintiff for the pregnancy, \nthe trier of fact may not find that the defendant committed malpractice \nand may not assess damages against the defendant unless the malpractice \nis proven by clear and convincing evidence.\n    (b) Applicability to Group Practices or Agreements Among \nProviders.--For purposes of subsection (a), a health care professional \nshall be considered to have previously treated an individual for a \npregnancy if the professional is a member of a group practice whose \nmembers previously treated the individual for the pregnancy or is \nproviding services to the individual during labor or the delivery of a \nbaby pursuant to an agreement with another professional.\n\nSEC. 206. UNIFORM STANDARD FOR DETERMINING NEGLIGENCE.\n\n    (a) Standard of Reasonableness.--Except as provided in subsection \n(b), a defendant may not be found to have committed malpractice unless \nthe defendant's conduct at the time of providing the health care \nservices that are the subject of the action was not reasonable.\n    (b) Actions Brought Under Strict Liability.--Subsection (a) shall \nnot apply to any action in which the claimant asserts that the \ndefendant is liable under a theory of strict liability.\n\nSEC. 207. RESTRICTIONS ON PUNITIVE DAMAGES RELATING TO MEDICAL PRODUCT \n              LIABILITY CLAIMS.\n\n    (a) Restrictions for Approved Products or Devices.--\n            (1) In general.--Punitive damages otherwise permitted by \n        applicable law shall not be awarded with respect to any medical \n        product liability claim alleged against a medical product \n        producer if--\n                    (A) the drug or device that is the subject of such \n                claim--\n                            (i) was subject to approval under section \n                        505 or premarket approval under section 515 of \n                        the Federal Food, Drug, and Cosmetic Act by the \n                        Food and Drug Administration with respect to--\n                                    (I) the safety of the formulation \n                                or performance of the aspect of the \n                                drug or device; or\n                                    (II) the adequacy of the packaging \n                                or labeling of the drug or device, and\n                            (ii) was approved by the Food and Drug \n                        Administration; or\n                    (B) the drug or device is generally recognized as \n                safe and effective pursuant to conditions established \n                by the Food and Drug Administration and applicable \n                regulations, including packaging and labeling \n                regulations.\n            (2) Exception in case of withheld information, \n        misrepresentation, or illegal payment.--The provisions of \n        paragraph (1) shall not apply if it is determined on the basis \n        of clear and convincing evidence that the medical product \n        producer--\n                    (A) withheld from or misrepresented to the Food and \n                Drug Administration information concerning such drug or \n                device that is required to be submitted under the \n                Federal Food, Drug, and Cosmetic Act or section 352 of \n                the Public Health Service Act that is material and \n                relevant to the action; or\n                    (B) made an illegal payment to an official of the \n                Food and Drug Administration for the purpose of \n                securing approval of the drug or device.\n    (b) Separate Proceeding To Determine Punitive Damages.--\n            (1) Considerations.--At the request of a medical product \n        producer in a health care liability action in which a medical \n        product liability claim is alleged against the producer, the \n        trier of fact shall consider in a separate proceeding--\n                    (A) whether punitive damages are to be awarded and \n                the amount of the award; or\n                    (B) the amount of punitive damages following a \n                determination of punitive liability.\n            (2) Evidence.--If a separate proceeding is requested in \n        accordance with paragraph (1), evidence relevant only to the \n        claim of punitive damages (as determined by applicable State \n        law) shall be inadmissible in any proceeding to determine \n        whether compensatory damages are to be awarded to the claimant.\n    (c) Criteria for Determining Amount of Punitive Damages.--Subject \nto the limitation on punitive damages provided in section 202(e), all \nrelevant evidence shall be considered in determining the amount of \npunitive damages assessed with respect to a medical product liability \nclaim, including--\n            (1) the financial condition of the medical product \n        producer;\n            (2) the severity of the harm caused by the conduct of the \n        medical product producer;\n            (3) the duration of the conduct or any concealment of the \n        conduct by the medical product producer;\n            (4) the profitability of the conduct to the medical product \n        producer;\n            (5) the number of products sold by the medical product \n        producer of the kind causing the harm complained of by the \n        claimant;\n            (6) awards of punitive or exemplary damages to persons \n        similarly situated to the claimant;\n            (7) prospective awards of compensatory damages to persons \n        similarly situated to the claimant;\n            (8) any criminal penalties imposed on the medical product \n        producer as a result of the conduct complained of by the \n        claimant; and\n            (9) the amount of any civil fines assessed against the \n        defendant as a result of the conduct complained of by the \n        claimant.\n\nSEC. 208. JURISDICTION OF FEDERAL COURTS.\n\n    The district courts of the United States shall not have \njurisdiction of any health care liability action based on sections 1331 \nor 1337 of title 28, United States Code.\n\nSEC. 209. PREEMPTION.\n\n    (a) In General.--This title supersedes any State law only to the \nextent that the State law permits the recovery by a claimant or the \nassessment against a defendant of a greater amount of damages, permits \nthe awarding of a greater amount of attorneys' fees, establishes a \nlonger period during which a medical malpractice claim or medical \nproduct liability claim may be initiated, or establishes a less strict \nstandard of proof for determining whether a defendant has committed \nmalpractice, than the provisions of this title.\n    (b) Effect on Sovereign Immunity and Choice of Law or Venue.--\nNothing in this title shall be construed to--\n            (1) waive or affect any defense of sovereign immunity \n        asserted by any State under any provision of law;\n            (2) waive or affect any defense of sovereign immunity \n        asserted by the United States;\n            (3) affect the applicability of any provision of the \n        Foreign Sovereign Immunities Act of 1976;\n            (4) preempt State choice-of-law rules with respect to \n        claims brought by a foreign nation or a citizen of a foreign \n        nation; or\n            (5) affect the right of any court to transfer venue or to \n        apply the law of a foreign nation or to dismiss a claim of a \n        foreign nation or of a citizen of a foreign nation on the \n        ground in inconvenient forum.\n\n                                 \n\nHR 1572 IH----2\nHR 1572 IH----3"
}